Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: Rationale for therapeutic drug monitoring-guided dosage

International Journal of Clinical Pharmacology and Therapeutics

Volumn 42, Issue 10, 2004, Pages 556-560

  Meyer, B ^a   Traunmuller F ^a   Hamwi, A ^a   Hollenstein, U M ^a   Locker, G J ^a   Sperr, W R ^a   Staudinger, T ^a   Thalhammer Scherrer, R ^a   Burgmann, H ^a   Thalhammer, Florian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adsorption; CVVH; High permeable polyamide membrane; Pharmacokinetics; Teicoplanin

Indexed keywords

ANTIINFECTIVE AGENT; POLYAMIDE; TEICOPLANIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; CASE REPORT; DRUG BINDING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MONITORING; HEMOFILTRATION; HUMAN; MEMBRANE FILTER; MEMBRANE PERMEABILITY; STATISTICAL SIGNIFICANCE;

EID: 6344243414     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP42556     Document Type: Article

References (17)

1. Bonatti M, Traina GL, Rosina R, Buvina G 1988 Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment. J Antimicrob Chemother 21 (Suppl A): 29-37
2. Gabutti L, Taminelli-Beltraminelli L, Marone C 1997 Clearance of ceftriaxone during hemodialysis using cuprophane, hemophane and polysulfone dialyzers. Eur J Clin Pharmacol 53: 123-126
3. Höffler D, Koepp P, Naumann E, Lang E, Sörgel F 1991 Pharmacokinetics of teicoplanin in hemodialysis patients. Infection 19: 324-327
4. Jorstad S, Smeby L, Balstrad T, Wideroe J 1988 Removal, generation and adsorption of beta2-microglobulin during hemofiltration with five different membranes. Blood Purif 6: 96-105
5. Joy MS, Matzke GR, Frye RF, Palevsky PM 1998 Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous hemodialysis. Am J Kidney Dis 31: 1019-1027
6. Joynt GM, Lipman J, Gomesall CD, Young RJ, Wong ELY, Gin T 2001 The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients. J Antimicrob Chemother 47: 421-429
7. Kroh UF, Dinges GK, Lukasewitz P, Steinhäusser WU, Holl TJ, Lennartz H 1998 Elimination of drugs by the new polyamide hemofilter FH77H during various in vitro conditions. Blood Purif 16 49-56
8. Lanese DM, Alfrey PS, Molitoris BA 1989 Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers. Kidney Int 25: 438-442
9. Menth M, Fiegel P 1992 Elimination of teicoplanin via different dialysis membranes: in vitro investigation. Int J Antimicrob Agents 1 (Suppl 1): 45-48
10. Meyer B, Ahmed el Gendy S, Delle Karth G, Locker GJ, Heinz G, Jäger W, Thalhammer F 2003 How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin. Kidney Blood Press Res 26: 135-140
11. Neville LO, Baillod R, Grady D, Brumfitt W, Hamilton-Miller JM 1987 Teicoplanin in patients with chronic renal failure on dialysis: microbiological and pharmacokinetic aspects. Int J Clin Pharmacol Res 7: 485-490
12. Papaioannou MG, Marinaki S, Pappas M, Stamatiadis D, Giamarellos-Bourboulis EJ, Giamarellou H, Stathakis C 2002 Pharmacokinetics of teicoplanin in patients undergoing chronic hemodialysis. Int J Antimicrob Agents 19: 233-236
13. Pea F, Brollo L, Lugano M, Dal Pos L, Furlanut M 2001 Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration. Ther Drug Monit 23: 587-588
14. Thalhammer F, Rosenkranz AR, Burgmann H, Graninger W, Hollenstein U, Schenk P, Thalhammer-Scherrer R, Traindl O, Hörl WH, Breyer S 1997 Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes. Wien Klin Wochenschr 109: 362-365
15. Thalhammer F, Schenk P, Burgmann H, El Menyawi I, Hollenstein U, Rosenkranz AR, Sunder-Plassmann G, Breyer S, Ratheiser K 1998 Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration. Antimicrob Agents Chemother 42: 2417-2420
16. Wilson AP 2000 Clinical pharmacokinetics of teicoplanin. Clin Pharmacokinet 39: 167-183
17. Wolter K, Claus M, Wagner K, Fritschka E 1994 Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous venovenous hemodialysis. Clin Nephrol 42: 389-397